{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:57:34Z","timestamp":1794592654243,"version":"4.9.1"},"reference-count":133,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.mayocp.2014.10.007","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T14:50:22Z","timestamp":1414680622000},"page":"12-23","source":"Crossref","is-referenced-by-count":387,"title":["The Safety of Intravenous Iron Preparations"],"prefix":"10.1016","volume":"90","author":[{"given":"Tomer","family":"Avni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hefziba","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Gafter-Gvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2257.2004.00664.x","article-title":"The impact of anaemia on outcome in cancer","volume":"27","author":"Clarke","year":"2005","journal-title":"Clinical and laboratory haematology"},{"issue":"10","key":"10.1016\/j.mayocp.2014.10.007_bib2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients a systematic review and meta-analysis","volume":"52","author":"Groenveld","year":"2008","journal-title":"J\u00a0Am Coll Caridiol"},{"key":"10.1016\/j.mayocp.2014.10.007_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1182\/asheducation-2010.1.338","article-title":"Clinical use of intravenous iron: administration, efficacy, and safety","volume":"2010","author":"Auerbach","year":"2010","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"10","key":"10.1016\/j.mayocp.2014.10.007_bib4","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/j.1537-2995.2007.01415.x","article-title":"Short-term benefits and risks of intravenous iron: a systematic review and meta-analysis","volume":"47","author":"Notebaert","year":"2007","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.mayocp.2014.10.007_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/eurjhf\/hfs017","article-title":"Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis","volume":"14","author":"Avni","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.mayocp.2014.10.007_bib6","doi-asserted-by":"crossref","first-page":"e75540","DOI":"10.1371\/journal.pone.0075540","article-title":"Treatment of anemia in inflammatory bowel disease- systematic review and meta-analysis","volume":"8","author":"Avni","year":"2013","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.mayocp.2014.10.007_bib7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2008.05.033","article-title":"Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis","volume":"52","author":"Rozen-Zvi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mayocp.2014.10.007_bib8","first-page":"CD007857","article-title":"Parenteral versus oral iron therapy for adults and children with chronic kidney disease","volume":"1","author":"Albaramki","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000358336","article-title":"Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis","volume":"39","author":"Susantitaphong","year":"2014","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/0284186X.2012.702921","article-title":"Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia: systematic review and meta-analysis of randomised controlled trials","volume":"52","author":"Gafter-Gvili","year":"2013","journal-title":"Acta Oncol"},{"issue":"10","key":"10.1016\/j.mayocp.2014.10.007_bib11","first-page":"CD003094","article-title":"Treatments for iron-deficiency anaemia in pregnancy","author":"Reveiz","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mayocp.2014.10.007_bib12","doi-asserted-by":"crossref","first-page":"f4822","DOI":"10.1136\/bmj.f4822","article-title":"Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials","volume":"347","author":"Litton","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/ajkd.2000.8276","article-title":"Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial","volume":"36","author":"Van Wyck","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.mayocp.2014.10.007_bib14","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/ndt\/gfh811","article-title":"Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients","volume":"20","author":"Walters","year":"2005","journal-title":"Nephrol Dial Tranplant"},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/ajkd.2002.33917","article-title":"Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury","volume":"40","author":"Zager","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"25","key":"10.1016\/j.mayocp.2014.10.007_bib16","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"4, suppl 2","key":"10.1016\/j.mayocp.2014.10.007_bib17","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1053\/ajkd.1999.v34.aajkd0344b0047","article-title":"Review of issues relating to iron and infection","volume":"34","author":"Fishbane","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.mayocp.2014.10.007_bib18","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1537-2995.2011.03495.x","article-title":"Iron deficiency syndromes and iron-restricted erythropoiesis (CME)","volume":"52","author":"Goodnough","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.mayocp.2014.10.007_bib19","unstructured":"Higgins J, Churchill R, Cumpston M, Chandler J, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. Oxford, England: Cochrane Collaboration;\u00a02011."},{"issue":"5","key":"10.1016\/j.mayocp.2014.10.007_bib20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.mayocp.2014.10.007_bib21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mayocp.2014.10.007_bib22","series-title":"National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE)","year":"2012"},{"key":"10.1016\/j.mayocp.2014.10.007_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2288-7-5","article-title":"Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data","volume":"7","author":"Friedrich","year":"2007","journal-title":"BMC Med Res Methodol"},{"issue":"183","key":"10.1016\/j.mayocp.2014.10.007_bib24","first-page":"133","article-title":"Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy","volume":"51","author":"Adhikary","year":"2011","journal-title":"JNMA J Nepal Med Assoc"},{"issue":"5","key":"10.1016\/j.mayocp.2014.10.007_bib25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000096174","article-title":"A\u00a0randomized controlled trial of oral versus intravenous iron in chronic kidney disease","volume":"26","author":"Agarwal","year":"2006","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.mayocp.2014.10.007_bib26","first-page":"170","article-title":"Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin","volume":"51","author":"Aggarwal","year":"2003","journal-title":"J\u00a0Associ Physicians India"},{"issue":"6","key":"10.1016\/j.mayocp.2014.10.007_bib27","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/01.AOG.0000185260.82466.b4","article-title":"Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial","volume":"106","author":"Al","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000186246","article-title":"Iron deficiency in maintenance hemodialysis patients: assessment of diagnosis criteria and of three different iron treatments","volume":"57","author":"Allegra","year":"1991","journal-title":"Nephron"},{"issue":"9","key":"10.1016\/j.mayocp.2014.10.007_bib29","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.sleep.2011.06.009","article-title":"Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial","volume":"12","author":"Allen","year":"2011","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0301-2115(95)02538-3","article-title":"Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy","volume":"69","author":"Al-Momen","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"suppl 2009, 2","key":"10.1016\/j.mayocp.2014.10.007_bib31","first-page":"ii71","article-title":"The safety of intravenous (IV) ferric carboxymaltose versus IV iron sucrose on patients with chronic heart failure (CHF) and chronic kidney disease (CKD) with iron deficincy (ID)","volume":"8","author":"Arutyunov","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.mayocp.2014.10.007_bib32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ygyno.2013.09.028","article-title":"Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy","volume":"131","author":"Athibovonsuk","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.mayocp.2014.10.007_bib33","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.2004.08.119","article-title":"Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial","volume":"22","author":"Auerbach","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.mayocp.2014.10.007_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ajh.21779","article-title":"Darbepoetin alfa 300 or 500 mug once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia","volume":"85","author":"Auerbach","year":"2010","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/apt.12556","article-title":"Randomised clinical trial: oral vs. intravenous iron after upper gastrointestinal haemorrhage: a placebo-controlled study","volume":"39","author":"Bager","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1542-4758.2009.00409.x","article-title":"Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia","volume":"14","author":"Bailie","year":"2010","journal-title":"Hemodial Int"},{"issue":"10","key":"10.1016\/j.mayocp.2014.10.007_bib37","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.2006.10.4620","article-title":"Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia","volume":"26","author":"Bastit","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2014.10.007_bib38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1067\/mob.2002.121894","article-title":"Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route","volume":"186","author":"Bayoumeu","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.mayocp.2014.10.007_bib39","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.ijcard.2013.04.181","article-title":"IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia","volume":"168","author":"Beck-da-Silva","year":"2013","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.mayocp.2014.10.007_bib40","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/ajh.23552","article-title":"Darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial","volume":"88","author":"Beguin","year":"2013","journal-title":"Am J Hematol"},{"issue":"18 suppl","key":"10.1016\/j.mayocp.2014.10.007_bib41","doi-asserted-by":"crossref","first-page":"9109","DOI":"10.1200\/jco.2007.25.18_suppl.9109","article-title":"A\u00a0phase III randomized controlled study comparing iron sucrose intravenously (IV) to no iron treatment of anemia in cancer patients undergoing chemotherapy and erythropoietin stimulating agent (ESA) therapy","volume":"25","author":"Bellet","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejogrb.2009.03.006","article-title":"Iron prophylaxis in pregnancy: intravenous route versus oral route","volume":"144","author":"Bencaiova","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"11","key":"10.1016\/j.mayocp.2014.10.007_bib43","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1471-0528.2006.01062.x","article-title":"Intravenous versus oral iron therapy for postpartum anaemia","volume":"113","author":"Bhandal","year":"2006","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.mayocp.2014.10.007_bib44","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1423-0410.2010.01368.x","article-title":"High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron","volume":"99","author":"Birgegard","year":"2010","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijgo.2007.10.009","article-title":"Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia","volume":"101","author":"Breymann","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.1016\/j.mayocp.2014.10.007_bib46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0899-9007(96)00095-0","article-title":"Effect of iron-supplemented total parenteral nutrition in patients with iron deficiency anemia","volume":"12","author":"Burns","year":"1996","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.mayocp.2014.10.007_bib47","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/ndt\/gfs528","article-title":"Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study","volume":"28","author":"Charytan","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.mayocp.2014.10.007_bib48","doi-asserted-by":"crossref","first-page":"c55","DOI":"10.1159\/000085049","article-title":"Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis","volume":"100","author":"Charytan","year":"2005","journal-title":"Nephron Clin Pract"},{"issue":"3","key":"10.1016\/j.mayocp.2014.10.007_bib49","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study","volume":"18","author":"Coyne","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.mayocp.2014.10.007_bib50","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ygyno.2009.12.004","article-title":"Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy","volume":"116","author":"Dangsuwan","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib51","first-page":"159","article-title":"Total infusion of low molecular weight iron-dextran for treating postpartum anemia","volume":"38","author":"Daniilidis","year":"2011","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.mayocp.2014.10.007_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1471-0528.1965.tb01378.x","article-title":"Parenteral iron therapy in pregnancy","volume":"72","author":"Dawson","year":"1965","journal-title":"J\u00a0Obstet Gynaecol of the Br Commonw"},{"issue":"4","key":"10.1016\/j.mayocp.2014.10.007_bib53","first-page":"314","article-title":"Comparison of efficacy and safety of two parenteral iron preparations in pregnant women","volume":"3","author":"Dhanani","year":"2012","journal-title":"J\u00a0Pharmacol Pharmcother"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib54","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.sleep.2007.12.006","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome","volume":"10","author":"Earley","year":"2009","journal-title":"Sleep Med"},{"issue":"10","key":"10.1016\/j.mayocp.2014.10.007_bib55","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/bjs.6688","article-title":"Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery","volume":"96","author":"Edwards","year":"2009","journal-title":"Br J Surg"},{"issue":"9","key":"10.1016\/j.mayocp.2014.10.007_bib56","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1080\/00365520510023198","article-title":"Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease","volume":"40","author":"Erichsen","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.mayocp.2014.10.007_bib57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cgh.2012.10.013","article-title":"Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease","volume":"11","author":"Evstatiev","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0272-6386(95)90151-5","article-title":"Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation","volume":"26","author":"Fishbane","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.mayocp.2014.10.007_bib59","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3109\/14767058.2012.746299","article-title":"Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial","volume":"26","author":"Froessler","year":"2013","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"6","key":"10.1016\/j.mayocp.2014.10.007_bib60","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/icvts\/ivs344","article-title":"The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial","volume":"15","author":"Garrido-Martin","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib61","first-page":"38","article-title":"Intravenous administration of iron sucrose for treating anemia in postpartum women","volume":"13","author":"Giannoulis","year":"2009","journal-title":"Hippokratia"},{"issue":"10","key":"10.1016\/j.mayocp.2014.10.007_bib62","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/mds.22562","article-title":"A\u00a0randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome","volume":"24","author":"Grote","year":"2009","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.mayocp.2014.10.007_bib63","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.leu.2404562","article-title":"Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study","volume":"21","author":"Hedenus","year":"2007","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1634\/theoncologist.12-2-231","article-title":"Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy","volume":"12","author":"Henry","year":"2007","journal-title":"Oncologist"},{"issue":"1-2","key":"10.1016\/j.mayocp.2014.10.007_bib65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1440-1797.1998.tb00329.x","article-title":"Experience of iron saccharate supplementation in haemodialysis patients treated with erythropoietin","volume":"4","author":"Hussain","year":"1998","journal-title":"Nephrology"},{"key":"10.1016\/j.mayocp.2014.10.007_bib66","unstructured":"Kalra P, Thomsen L. Effect of iron isomaltoside 1000 on phosphate levels in patients with non-dialysis dependent chronic kidney disease. American Society of Nephrology, kidney week 2012 abstract supplement, page 687A. https:\/\/www.asn-online.org\/education\/kidneyweek\/archives\/. Accessed February 19, 2013."},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF03021522","article-title":"Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia","volume":"53","author":"Karkouti","year":"2006","journal-title":"Can J Anaesth"},{"issue":"3","key":"10.1016\/j.mayocp.2014.10.007_bib68","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2796.2010.02251.x","article-title":"A\u00a0prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy","volume":"268","author":"Khalafallah","year":"2010","journal-title":"J\u00a0Intern Med"},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000210062","article-title":"Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study","volume":"121","author":"Kim","year":"2009","journal-title":"Acta Haematol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib70","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ygyno.2006.11.014","article-title":"Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy","volume":"105","author":"Kim","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib71","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1447-0756.2012.01982.x","article-title":"Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial","volume":"39","author":"Kochhar","year":"2013","journal-title":"J\u00a0Obstet Gynaecol Res"},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib72","first-page":"63","article-title":"Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin","volume":"48","author":"Kotaki","year":"1997","journal-title":"Clin Nephrol"},{"issue":"12","key":"10.1016\/j.mayocp.2014.10.007_bib73","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2011-04-346304","article-title":"Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration","volume":"118","author":"Krayenbuehl","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mayocp.2014.10.007_bib74","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1572-0241.2007.01744.x","article-title":"A\u00a0novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial","volume":"103","author":"Kulnigg","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.mayocp.2014.10.007_bib75","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/MIB.0b013e318281f4db","article-title":"Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial","volume":"19","author":"Kulnigg-Dabsch","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2014.10.007_bib76","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1681\/ASN.2007101084","article-title":"Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients","volume":"19","author":"Kuo","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/089686080802800210","article-title":"Intravenous iron sucrose in peritoneal dialysis patients with renal anemia","volume":"28","author":"Li","year":"2008","journal-title":"Perit Dial Int"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib78","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000113529","article-title":"Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia","volume":"26","author":"Li","year":"2008","journal-title":"Blood Purif"},{"issue":"7","key":"10.1016\/j.mayocp.2014.10.007_bib79","first-page":"457","article-title":"Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study","volume":"89","author":"Li","year":"2009","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"7","key":"10.1016\/j.mayocp.2014.10.007_bib80","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/00365520902839667","article-title":"Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study","volume":"44","author":"Lindgren","year":"2009","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1016\/j.mayocp.2014.10.007_bib81","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/ki.1996.487","article-title":"A\u00a0randomized controlled study of iron supplementation in patients treated with erythropoietin","volume":"50","author":"Macdougall","year":"1996","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.jvca.2003.10.012","article-title":"Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery","volume":"18","author":"Madi-Jebara","year":"2004","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"3","key":"10.1016\/j.mayocp.2014.10.007_bib83","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/ndt\/gfp584","article-title":"Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial","volume":"25","author":"McMahon","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.mayocp.2014.10.007_bib84","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1046\/j.1523-1755.2002.00314.x","article-title":"Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran","volume":"61","author":"Michael","year":"2002","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.mayocp.2014.10.007_bib85","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/TP.0b013e318248375a","article-title":"A\u00a0randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation","volume":"93","author":"Mudge","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.mayocp.2014.10.007_bib86","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2369-14-64","article-title":"Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial","volume":"14","author":"Nagaraju","year":"2013","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.mayocp.2014.10.007_bib87","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4103\/0970-0218.103467","article-title":"Iron sucrose versus oral iron therapy in pregnancy anemia","volume":"37","author":"Neeru","year":"2012","journal-title":"Ind J Community Med"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib88","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.mayocp.2014.10.007_bib89","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1537-2995.2001.41070957.x","article-title":"Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial","volume":"41","author":"Olijhoek","year":"2001","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.mayocp.2014.10.007_bib90","first-page":"626","article-title":"Iron deficiency anaemia during pregnancy a comparative trial of treatment by iron-poly (sorbitol-gluconic acid) complex Ferastral given intramuscularly and iron dextran (Imferon) by total dose infusion","volume":"57","author":"Oluboyede","year":"1980","journal-title":"East Afr Med J"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib91","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/trf.12289","article-title":"A\u00a0multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia","volume":"54","author":"Onken","year":"2014","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.mayocp.2014.10.007_bib92","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1200\/JCO.2007.12.2051","article-title":"Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha","volume":"26","author":"Pedrazzoli","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib93","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2215\/CJN.02840608","article-title":"Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients","volume":"4","author":"Provenzano","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.mayocp.2014.10.007_bib94","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/ndt\/gfq613","article-title":"A\u00a0randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients","volume":"26","author":"Qunibi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.mayocp.2014.10.007_bib95","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/ajg.2013.335","article-title":"A\u00a0randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED)","volume":"108","author":"Reinisch","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.mayocp.2014.10.007_bib96","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/152581600419161","article-title":"Intravenous versus oral iron supplementation for preoperative stimulation of hemoglobin synthesis using recombinant human erythropoietin","volume":"9","author":"Rohling","year":"2000","journal-title":"J\u00a0Hemother Stem Cell Res"},{"issue":"6","key":"10.1016\/j.mayocp.2014.10.007_bib97","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1111\/j.1523-1755.2005.00754.x","article-title":"Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients","volume":"68","author":"Schaller","year":"2005","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.mayocp.2014.10.007_bib98","first-page":"236","article-title":"Effectiveness of oral versus parenteral iron substitution in autologous blood donors","volume":"21","author":"Schindler","year":"1994","journal-title":"Infusionsther Transfusionsmed"},{"issue":"11","key":"10.1016\/j.mayocp.2014.10.007_bib99","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/j.1572-0241.2005.00250.x","article-title":"Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease: a randomized, controlled, open-label, multicenter study","volume":"100","author":"Schroder","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.mayocp.2014.10.007_bib100","doi-asserted-by":"crossref","first-page":"435.e1","DOI":"10.1016\/j.ajog.2008.07.046","article-title":"Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial","volume":"199","author":"Seid","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib101","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1537-2995.2010.02769.x","article-title":"Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial","volume":"51","author":"Serrano-Trenas","year":"2011","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.mayocp.2014.10.007_bib102","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13224-012-0222-0","article-title":"Iron deficiency anemia in pregnancy: intravenous versus oral route","volume":"62","author":"Shafi","year":"2012","journal-title":"J\u00a0Obstet Gynaecol India"},{"issue":"5","key":"10.1016\/j.mayocp.2014.10.007_bib103","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1053\/j.ajkd.2008.08.001","article-title":"Safety of ferumoxytol in patients with anemia and CKD","volume":"52","author":"Singh","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2014.10.007_bib104","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2215\/CJN.01541005","article-title":"Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial","volume":"1","author":"Singh","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0609.1998.tb01008.x","article-title":"A\u00a0comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy","volume":"60","author":"Singh","year":"1998","journal-title":"Eur J Haemotol"},{"issue":"4","key":"10.1016\/j.mayocp.2014.10.007_bib106","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/j.ajkd.2003.11.021","article-title":"A\u00a0double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome","volume":"43","author":"Sloand","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2014.10.007_bib107","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1079\/BJN19790130","article-title":"WHO sponsored collaborative studies on nutritional anaemia in India. The effect of parenteral iron administration in the control of anaemia of pregnancy","volume":"42","author":"Sood","year":"1979","journal-title":"Br J Nutr"},{"issue":"8","key":"10.1016\/j.mayocp.2014.10.007_bib108","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1681\/ASN.2007101156","article-title":"Ferumoxytol for treating iron deficiency anemia in CKD","volume":"19","author":"Spinowitz","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib109","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1200\/JCO.2010.30.3644","article-title":"Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia","volume":"29","author":"Steensma","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.mayocp.2014.10.007_bib110","first-page":"195","article-title":"Iron dextran in the treatment of iron-deficiency anaemia of pregnancy: haematological response and incidence of side-effects","volume":"79","author":"Stein","year":"1991","journal-title":"S\u00a0Afr Med J"},{"issue":"5","key":"10.1016\/j.mayocp.2014.10.007_bib111","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ndt\/16.5.967","article-title":"A\u00a0randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin","volume":"16","author":"Stoves","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib112","first-page":"55","article-title":"The therapeutic equivalence of oral and intravenous iron in renal dialysis patients","volume":"7","author":"Strickland","year":"1977","journal-title":"Clin Nephrol"},{"issue":"12","key":"10.1016\/j.mayocp.2014.10.007_bib113","first-page":"849","article-title":"Iron supplementation during erythropoietin therapy in patients on hemodialysis","volume":"42","author":"Svara","year":"1996","journal-title":"Vnitr Lek"},{"issue":"3","key":"10.1016\/j.mayocp.2014.10.007_bib114","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/ham.2011.1005","article-title":"Intravenous iron supplementation may protect against acute mountain sickness: a randomized, double-blinded, placebo-controlled trial","volume":"12","author":"Talbot","year":"2011","journal-title":"High Alt Med Biol"},{"issue":"17","key":"10.1016\/j.mayocp.2014.10.007_bib115","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.10.007_bib116","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ajh.23582","article-title":"Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron","volume":"89","author":"Vadhan-Raj","year":"2014","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.mayocp.2014.10.007_bib117","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1097\/00003246-200008000-00015","article-title":"Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients","volume":"28","author":"van Iperen","year":"2000","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.mayocp.2014.10.007_bib118","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1537-2995.2009.02327.x","article-title":"Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial","volume":"49","author":"Van Wyck","year":"2009","journal-title":"Transfusion"},{"issue":"2, pt 1","key":"10.1016\/j.mayocp.2014.10.007_bib119","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.AOG.0000275286.03283.18","article-title":"Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial","volume":"110","author":"Van Wyck","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.mayocp.2014.10.007_bib120","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1111\/j.1523-1755.2005.00758.x","article-title":"A\u00a0randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD","volume":"68","author":"Van Wyck","year":"2005","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib121","first-page":"67","article-title":"Intravenous iron therapy versus oral iron in postpartum patients in rural area","volume":"3","author":"Verma","year":"2011","journal-title":"J\u00a0S Asian Fed Obstet Gynaecol"},{"issue":"9","key":"10.1016\/j.mayocp.2014.10.007_bib122","first-page":"392","article-title":"Comparative study: efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy","volume":"52","author":"Wali","year":"2002","journal-title":"J\u00a0Pakistan Med Assoc"},{"issue":"5","key":"10.1016\/j.mayocp.2014.10.007_bib123","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1537-2995.1999.39050465.x","article-title":"Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study","volume":"39","author":"Weisbach","year":"1999","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.mayocp.2014.10.007_bib124","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1080\/00016340802317802","article-title":"A\u00a012-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia","volume":"87","author":"Westad","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"10.1016\/j.mayocp.2014.10.007_bib125","first-page":"844","article-title":"Multi-frequency low-dose intravenous iron on oxidative stress in maintenance hemodialysis patients","volume":"37","author":"Yin","year":"2012","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.mayocp.2014.10.007_bib126","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2326-11-4","article-title":"Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data","volume":"11","author":"Moore","year":"2011","journal-title":"BMC Blood Disord"},{"issue":"5","key":"10.1016\/j.mayocp.2014.10.007_bib127","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1681\/ASN.V95869","article-title":"EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients","volume":"9","author":"Hoen","year":"1998","journal-title":"J\u00a0AM Soc Nephrol"},{"issue":"6","key":"10.1016\/j.mayocp.2014.10.007_bib128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.5414\/CNP57457","article-title":"Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients","volume":"57","author":"Hoen","year":"2002","journal-title":"Clin Nephrol"},{"issue":"13","key":"10.1016\/j.mayocp.2014.10.007_bib129","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2014.2726","article-title":"Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis","volume":"311","author":"Rohde","year":"2014","journal-title":"JAMA"},{"issue":"9572","key":"10.1016\/j.mayocp.2014.10.007_bib130","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(07)60689-8","article-title":"Clinical update: intravenous iron for anaemia","volume":"369","author":"Auerbach","year":"2007","journal-title":"Lancet"},{"issue":"10, suppl 1","key":"10.1016\/j.mayocp.2014.10.007_bib131","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2146\/ajhp110039","article-title":"Iron replacement therapy in cancer-related anemia","volume":"68","author":"Baribeault","year":"2011","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.mayocp.2014.10.007_bib132","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bjh.12547","article-title":"Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety","volume":"163","author":"Bolton-Maggs","year":"2013","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.mayocp.2014.10.007_bib133","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ndt\/gfi253","article-title":"Update on adverse drug events associated with parenteral iron","volume":"21","author":"Chertow","year":"2006","journal-title":"Nephrol Dial Transplant"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619614008830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619614008830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T10:54:36Z","timestamp":1717498476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619614008830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":133,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0025619614008830"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2014.10.007","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}